FR2358881A1 - Composition pharmaceutique active sur le systeme nerveux central - Google Patents

Composition pharmaceutique active sur le systeme nerveux central

Info

Publication number
FR2358881A1
FR2358881A1 FR7622045A FR7622045A FR2358881A1 FR 2358881 A1 FR2358881 A1 FR 2358881A1 FR 7622045 A FR7622045 A FR 7622045A FR 7622045 A FR7622045 A FR 7622045A FR 2358881 A1 FR2358881 A1 FR 2358881A1
Authority
FR
France
Prior art keywords
neuroleptic
schizophrenia
compsn
treating
gabamimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7622045A
Other languages
English (en)
French (fr)
Other versions
FR2358881B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7622045A priority Critical patent/FR2358881A1/fr
Priority to IL52550A priority patent/IL52550A/xx
Priority to NZ184666A priority patent/NZ184666A/xx
Priority to IE1509/77A priority patent/IE45454B1/en
Priority to SE7708349A priority patent/SE7708349L/
Priority to CA283,049A priority patent/CA1077846A/en
Priority to LU77796A priority patent/LU77796A1/xx
Priority to AU27151/77A priority patent/AU508753B2/en
Priority to GB30355/77A priority patent/GB1556567A/en
Priority to BE179459A priority patent/BE856937A/xx
Priority to DE19772732614 priority patent/DE2732614A1/de
Priority to ZA00774376A priority patent/ZA774376B/xx
Priority to JP8785277A priority patent/JPS5326327A/ja
Priority to NL7708055A priority patent/NL7708055A/xx
Publication of FR2358881A1 publication Critical patent/FR2358881A1/fr
Application granted granted Critical
Publication of FR2358881B1 publication Critical patent/FR2358881B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7622045A 1976-07-20 1976-07-20 Composition pharmaceutique active sur le systeme nerveux central Granted FR2358881A1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (fr) 1976-07-20 1976-07-20 Composition pharmaceutique active sur le systeme nerveux central
NZ184666A NZ184666A (en) 1976-07-20 1977-07-18 Pharmaceutical compositions comprising a gabamimetic compound and a neuroleptic compound
IL52550A IL52550A (en) 1976-07-20 1977-07-18 Pharmaceutical compositions having an action on the central nervous system coprising a gabamimetic compound and a neuroleptic compound
AU27151/77A AU508753B2 (en) 1976-07-20 1977-07-19 Central nervous system pharmaceuticals
CA283,049A CA1077846A (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system
LU77796A LU77796A1 (enrdf_load_stackoverflow) 1976-07-20 1977-07-19
IE1509/77A IE45454B1 (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system
GB30355/77A GB1556567A (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system
BE179459A BE856937A (fr) 1976-07-20 1977-07-19 Compositions pharmaceutiques actives sur le systeme nerveux central
DE19772732614 DE2732614A1 (de) 1976-07-20 1977-07-19 Arzneimittel mit wirkung auf das zentralnervensystem
SE7708349A SE7708349L (sv) 1976-07-20 1977-07-19 Farmaceutiska kompositioner och forfarande for framstellning derav
JP8785277A JPS5326327A (en) 1976-07-20 1977-07-20 Medical composition active to central nerve system
ZA00774376A ZA774376B (en) 1976-07-20 1977-07-20 Pharmaceutical compositions having an action on the central nervous system
NL7708055A NL7708055A (nl) 1976-07-20 1977-07-20 Werkwijze voor het bereiden van een geneesmid- del en zo gevormd geneesmiddel.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (fr) 1976-07-20 1976-07-20 Composition pharmaceutique active sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
FR2358881A1 true FR2358881A1 (fr) 1978-02-17
FR2358881B1 FR2358881B1 (enrdf_load_stackoverflow) 1980-10-03

Family

ID=9175888

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7622045A Granted FR2358881A1 (fr) 1976-07-20 1976-07-20 Composition pharmaceutique active sur le systeme nerveux central

Country Status (3)

Country Link
BE (1) BE856937A (enrdf_load_stackoverflow)
FR (1) FR2358881A1 (enrdf_load_stackoverflow)
ZA (1) ZA774376B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018127A1 (en) * 1991-04-15 1992-10-29 The Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018127A1 (en) * 1991-04-15 1992-10-29 The Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
US5231099A (en) * 1991-04-15 1993-07-27 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs

Also Published As

Publication number Publication date
BE856937A (fr) 1978-01-19
ZA774376B (en) 1978-06-28
FR2358881B1 (enrdf_load_stackoverflow) 1980-10-03

Similar Documents

Publication Publication Date Title
DE3263734D1 (en) Derivatives of 1-aryl-2-aminomethyl-cyclopropane-carboxamides (z), their preparation and their use as medicines in the treatment of disorders of the central nervous system
DE2960820D1 (en) Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them
ES538418A0 (es) Un derivado de indol-3-carboxamida
GB8530602D0 (en) Heterocyclic compounds
FR2663328B1 (fr) Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2358881A1 (fr) Composition pharmaceutique active sur le systeme nerveux central
AU8441382A (en) Antiviral alpha alpha dialkyl adamantylethylamines
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
PT100891A (pt) Per-hidro-1h-pirido {1,2-a} pirazinas 2-substituidas neurolepticas
JPS5735515A (en) Immunoregulating agent
SE8200891L (sv) 2-amino-3-(halogenbensoyl)-metylfenylettiksyror samt estrar och salter derav
FR2369216A1 (fr) Produits pour le traitement d'eaux, contenant des acides acylimino diacetiques
BE896098A (fr) Procede de modulation de la reponse immunitaire avec des dibenzocycloheptenylidenes
IE822853L (en) 1-piperazino carboxylates
JPS5533453A (en) Preventive and remedy for infectious disease of fish
ZA874970B (en) Derivatives of 2,6-piperazinedione,their preparation processes and the pharmaceutical compositions containing them
ES8505367A1 (es) Procedimiento para la preparacion de derivados de acridanona
FR2674436B1 (fr) Nouvelle utilisation de sterouides 4,9,11-trieniques dans des compositions destinees a l'administration chez la dinde.
FR2244514A1 (en) 1,2-Dihydroquinoline derivs - useful as anti-inflammatories
MD1837B2 (ro) Derivaţi de spiro-[2H-1-benzopiran-2,4'-piperidin]-4(3H)-onă, săruri acide de adiţie şi cuaternare ale acestora şi compoziţii farmaceutice ce le conţin
FR2021123A1 (fr) Nouveaux derives du 1,3-diamino-propane-2-ol
DE3480542D1 (en) Cephem compounds
ES8602019A1 (es) Un procedimiento para preparar compuestos de cefalosporina
FR2085645A1 (en) 1-phenyl-2,3-benzodiazepin-4-ones - as tranquillizers
ES2069146T3 (es) Medicamentos que contienen derivados sustituidos de 2-ciclohexeno-1-il-amina y su uso para combatir enfermedades.

Legal Events

Date Code Title Description
ST Notification of lapse